Eli Lilly and Company (NYSE: LLY) announced that patients with moderate-to-severe plaque psoriasis who did not respond to treatment with ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE